<DOC>
	<DOCNO>NCT00755053</DOCNO>
	<brief_summary>The study focus prove efficacy new Canesten formulation ( ovule ) inferior old Canesten formulation ( tablet )</brief_summary>
	<brief_title>Comparative Efficacy Ovule v Tablet</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Vulvovaginal</mesh_term>
	<criteria>Nonpregnant female age least 14 year Germany least 16 year Russia old 50 year . Subjects present symptomatic vulvovaginal yeast infection confirm microscopic evaluation ( wet mount preparation ) . Subjects must cooperative , able understand requirement trial participation , willing participate trial . For adolescent informed consent provide legal representative addition . Subjects childbearing potential must use acceptable method contraception . Hormonal oral contraceptive drug , intrauterine device ( IUD ) abstinence consider acceptable method contraception . Negative saline smear Trichomonas vaginalis Subjects know hypersensitivity imidazole triazoles analogue . Subjects present protozoan infection confirm microscopic investigation . Pregnant , breast feeding lactate subject . Subjects suspect bacterial vaginal infection . Subjects abdominal pain , fever , foul smell vaginal discharge . Subjects vaginal infection , use intravaginal systemic antimycotic treatment within 60 day prior visit 1 . Subjects use wish use intravaginal systemic antiinfectives systemic antifungal therapy trial . Subjects wish use contraceptive foam , cream , jelly , sponge , therapeutic ointment , condom , diaphragm , OTC vaginal product treatment 3 day thereafter ( i.e . day 4 ) . Subjects unable refrain use vaginal tampon treatment 3 day thereafter ( i.e . day 4 ) . Subjects unable refrain use feminine hygiene product ( e.g . douche , feminine deodorant product ) 2 week ( i.e . visit 1 visit 2 ) . Subjects suffer chronic/recurrent vulvovaginal mycosis , define 4 mycologically proven symptomatic episode last 12 month . Subjects suffer disease ( e.g . diabetes , decrease cellular immunity ) treat drug ( e.g . immunosuppressant , corticosteroid , antiinfectives ) may predispose mycological infection . Subjects receive another investigational drug within 30 day visit 1 . Unwillingness refrain sexual activity 3 day thereafter . Actual menstruation visit 1 expect menstruation within 4 day visit 1 .</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Clotrimazole</keyword>
	<keyword>Ovule</keyword>
	<keyword>Tablet</keyword>
	<keyword>Vulvovaginal candidiasis</keyword>
	<keyword>Non-inferiority</keyword>
</DOC>